Partnering for future innovation in animal health

We know the combined power of innovation and collaboration can quickly revolutionize animal health. Our collective success in addressing unmet needs in animal health hinges on connecting with partners across the scientific community, so together we can pursue science and solutions and build a healthier future for animals.

200+

Collaborations worldwide contributing to our pipeline and portfolio

8 out of 10

Top-selling products anchored in partner collaborations

€500 million

Investment in R&D for future innovations in animal health

30%

Of our Pipeline anchored in external innovation

Collaboration driving innovation

We focus on delivering breakthrough innovation—wherever it originates—to tackle the most important scientific challenges we face. That’s why we’re one of the industry’s leading investors in animal health innovation. We’re investing in both external innovation and our own R&D to power our research and collectively provide solutions for some of the biggest challenges in animal health.

Outlook for 2025 – partnering for innovation in Animal Health

2024 was an exciting year for animal health partnering at Boehringer Ingelheim. As we enter 2025, Megan Grether, Global Head of Business Development and Licensing, Animal Health, reflects on the highlights of 2024 and shares her perspectives and priorities for partnering for the year ahead.

Where to Meet Us in 2025

We believe this is an exciting time in animal health with innovative science and groundbreaking solutions set to revolutionize treatment and care. However, there are still many unmet needs that make building connections within the animal health and broader scientific communities ever more crucial. Come and meet us and let’s work together to build a healthier future for animals.

Therapeutic vaccines: Applying innovative science to tackle chronic disease in pets

We’re embracing disruptive technology to work towards providing solutions for some of the biggest challenges in animal health. One of these challenges is tackling chronic disease in pets. Find out why we’re exploring therapeutic vaccines to help our pets live longer, healthier lives.

This year we’re especially focused on pet therapeutics, particularly allergic diseases, pain, cardio-renal-metabolic diseases, oncology, central nervous system diseases, and oral health. We’re also interested in opportunities that prevent infectious diseases in livestock.

Synergies across animal and human health

At Boehringer Ingelheim, we’ve seen how learning from each other can accelerate innovation in both human and animal health. Our continued success in addressing unmet needs in animal health relies not only on internal collaboration but also on working with external partners in animal health and human pharma, who bring valuable new ideas and new science to our collective innovation journey. Watch our Beyond Boundaries video to find out more.

References